25 years of HIV research! ... and what about a vaccine?

被引:6
|
作者
Appay, Victor [1 ]
机构
[1] Univ Paris 06, INSERM, Hop La Pitie Salpetriere, Avenir Grp,UMR S 945, F-75013 Paris, France
关键词
AIDS; Diversity; T-cells; Vaccine; CD8(+) T-CELLS; IMMUNODEFICIENCY VIRUS-INFECTION; IMMUNE CONTROL; NEUTRALIZING ANTIBODIES; ANTIRETROVIRAL THERAPY; DENDRITIC CELLS; RHESUS-MONKEYS; IN-VIVO; RESPONSES; ANTIGEN;
D O I
10.1002/eji.200939551
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Over the past quarter century, colossal progress in our understanding of HIV pathogenesis has been achieved. Yet, we have no solution to the pandemic; the search for an HIV vaccine remains among the highest public health priorities. Identifying correlates of immune protection in humans, inducing effective immunity through immunization, and overcoming virus and host diversity represent the major obstacles in vaccine development. HIV vaccine research discovery may only be at its dawn.
引用
收藏
页码:1999 / 2003
页数:5
相关论文
共 50 条
  • [1] What Has 30 Years of HIV Vaccine Research Taught Us?
    Esparza, Jose
    VACCINES, 2013, 1 (04):
  • [2] HIV and Messenger RNA Vaccine
    Khalid, Khizer
    Padda, Jaskamal
    Khedr, Anwar
    Ismail, Dina
    Zubair, Ujala
    Al-Ewaidat, Ola A.
    Padda, Sandeep
    Cooper, Ayden Charlene
    Jean-Charles, Gutteridge
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
  • [3] 25 Years after HIV Discovery: Prospects for Cure and Vaccine (Nobel Lecture)
    Montagnier, Luc
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2009, 48 (32) : 5815 - 5826
  • [4] Monkey Models and HIV Vaccine Research
    Chen, Zhiwei
    HIV VACCINES AND CURE: THE PATH TOWARDS FINDING AN EFFECTIVE CURE AND VACCINE, 2018, 1075 : 97 - 124
  • [5] The HIV Outpatient Study-25 Years of HIV Patient Care and Epidemiologic Research
    Buchacz, Kate
    Armon, Carl
    Palella, Frank J., Jr.
    Novak, Richard M.
    Fuhrer, Jack
    Tedaldi, Ellen
    Ward, Douglas
    Mayer, Cynthia
    Battalora, Linda
    Carlson, Kimberly
    Purinton, Stacey
    Durham, Marcus
    Li, Jun
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (05):
  • [6] An Update on the HIV DNA Vaccine Strategy
    Hokello, Joseph
    Sharma, Adhikarimayum Lakhikumar
    Tyagi, Mudit
    VACCINES, 2021, 9 (06)
  • [7] An underestimated lentivirus model: what can HIV-2 research contribute to the development of an effective HIV-1 vaccine?
    Hodges-Mameletzis, Ioannis
    De Bree, G. J.
    Rowland-Jones, Sarah L.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (02) : 195 - 206
  • [8] 25 years of HIV research on virology, virus restriction, immunopathogenesis, genes and vaccines
    Scherer, E.
    Douek, D.
    McMichael, A.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 154 (01) : 6 - 14
  • [9] An HIV-based lentiviral vector as HIV vaccine candidate: Immunogenic characterization
    Lemiale, Franck
    Asefa, Benyam
    Ye, Delia
    Chen, Christopher
    Korokhov, Nikolay
    Humeau, Laurent
    VACCINE, 2010, 28 (08) : 1952 - 1961
  • [10] Progress in HIV vaccine research
    van der Ryst, E
    ORAL DISEASES, 2002, 8 : 21 - 26